Benzinga's Top #PreMarket Gainers
May 01, 2014 at 08:08 AM EDT
Merrimack Pharmaceuticals (NASDAQ: MACK) shares jumped 73.12% to $7.60 in pre-market trading after the company reported that MM-398 has ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.